| Title |
The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries
|
|---|---|
| Published in |
Infection and Drug Resistance, December 2020
|
| DOI | 10.2147/idr.s288399 |
| Pubmed ID | |
| Authors |
Alison Dillman, Michael J Zoratti, Jay J H Park, Grace Hsu, Louis Dron, Gerald Smith, Ofir Harari, Craig R Rayner, Noor-E Zannat, Alind Gupta, Eric Mackay, Paul Arora, Zelyn Lee, Edward J Mills |
Mendeley readers
The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 101 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 14 | 14% |
| Researcher | 7 | 7% |
| Other | 7 | 7% |
| Student > Master | 6 | 6% |
| Student > Doctoral Student | 4 | 4% |
| Other | 11 | 11% |
| Unknown | 52 | 51% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 9% |
| Nursing and Health Professions | 7 | 7% |
| Biochemistry, Genetics and Molecular Biology | 5 | 5% |
| Mathematics | 2 | 2% |
| Other | 10 | 10% |
| Unknown | 55 | 54% |